Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin

Lancet. 1994 Oct 8;344(8928):1025-6. doi: 10.1016/s0140-6736(94)91687-x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Enterococcus faecium* / drug effects
  • Female
  • Gram-Positive Bacterial Infections / drug therapy*
  • Gram-Positive Bacterial Infections / etiology
  • Humans
  • Male
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Peritonitis / drug therapy*
  • Peritonitis / microbiology
  • Virginiamycin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Virginiamycin
  • quinupristin-dalfopristin